What is the newborn pulse oximetry screening? 

Newborn pulse oximetry screening is a simple, non-invasive test used to measure the amount of oxygen in a baby’s blood. Its primary purpose is to identify infants with critical Congenital Heart Disease (cCHD) before they leave the hospital. By detecting low oxygen levels that may not be visible to the naked eye, this screening allows for early intervention, significantly reducing the risk of serious complications or sudden collapse in the first days of life. 

Pulse oximetry screening is typically performed between 4 and 24 hours after birth. It is increasingly used across the UK as an addition to the Newborn Physical Examination (NIPE). Because some heart defects do not cause a heart murmur or visible blueness (cyanosis) immediately after birth, measuring oxygen saturation provides a critical physiological marker for cardiac health. The test is painless, takes only a few minutes, and involves no needles or radiation. 

What We’ll Discuss in This Article 

• How the pulse oximetry test is performed on newborns 

• Why this screening is essential for detecting critical CHD 

• Understanding the difference between ‘pass’ and ‘fail’ results 

• The biological transition from fetal to newborn circulation 

• What happens if a baby requires further cardiac investigation 

• Clinical data on the effectiveness of pulse oximetry screening 

How the Screening is Performed 

The screening uses a small device called a pulse oximeter, which features a sensor wrapped around the baby’s hand or foot. The sensor uses light to determine how much oxygen the red blood cells are carrying. In a clinical setting, healthcare providers usually check both the ‘pre-ductal’ (right hand) and ‘post-ductal’ (either foot) sites to compare the readings. 

The comparison between the hand and foot is vital because certain heart defects cause a significant difference in oxygen levels between the upper and lower body. According to NHS clinical guidelines (2024), a significant gap—usually more than 3%—between the two sites can be a marker for conditions like coarctation of the aorta or interrupted aortic arch. 

Why Timing Matters: Fetal vs. Newborn Circulation 

The timing of the test is crucial because of how a baby’s circulation changes at birth. In the womb, a vessel called the ductus arteriosus allows blood to bypass the lungs. Once a baby is born and begins to breathe, this vessel starts to close. 

• The ‘Window’ of Detection: If a baby has a heart defect that depends on that vessel staying open (duct-dependent lesions), they may appear perfectly healthy for the first few hours. 

• The Screening Advantage: Pulse oximetry can detect falling oxygen levels as the vessel begins to close, catching the defect before the baby becomes physically distressed or collapses. 

• Optimal Timing: Performing the test after 4 hours of life reduces the number of ‘false positives’ caused by the normal, slow transition of a newborn’s lungs. 

Understanding the Screening Results 

A ‘pass’ result indicates that the oxygen levels are within the expected healthy range for a newborn. An ‘abnormal’ or ‘fail’ result does not automatically mean the baby has a heart defect, but it does mean further investigation is required immediately. 

The table below outlines the standard clinical thresholds for newborn pulse oximetry: 

Screening Result	Oxygen Saturation Reading	Clinical Action
Pass	95% or higher in both hand/foot	Routine care continues
Repeat Required	90% – 94% or >3% difference	Retest in 1–2 hours
Abnormal (Fail)	Less than 90% at any time	Immediate medical review & Echocardiogram

It is important to note that low oxygen can also be caused by other common newborn issues, such as mild breathing difficulties, pneumonia, or early-stage infections (sepsis). 

Effectiveness and Clinical Evidence 

The implementation of pulse oximetry screening has fundamentally changed neonatal safety. Before this screening became widespread, some babies with critical heart defects were discharged from the hospital, only to become dangerously ill at home when their fetal circulation finally closed. 

‘Pulse oximetry screening is an invaluable safety net. It identifies roughly 75% of critical CHD cases when combined with the 20-week ultrasound and physical examination, ensuring babies receive life-saving surgery or treatment in time.’  Dr. Stefan Petrov 

Clinical data from the National Institute for Cardiovascular Outcomes Research (NICOR) indicates that early detection through these multi-layered screenings has contributed to the UK’s high survival rates for congenital heart surgery, which currently stand at over 98%. 

Source https://scts.org/_userfiles/pages/files/congential/nationalcongenitalheartdiseaseauditnchdafinal.pdf 

Conclusion 

Newborn pulse oximetry is a vital, non-invasive tool in the early detection of critical heart defects. By measuring oxygen levels in the first 24 hours of life, healthcare teams can identify babies who need specialist cardiac care before symptoms become severe. While a failed test can be worrying for parents, it ensures that the baby receives a prompt diagnosis and the necessary support to ensure a healthy start in life. 

If your baby has difficulty breathing, a blue tinge to their skin/lips, or is too tired to feed, call 999 immediately. 

If you notice your baby is unusually pale, cold to the touch, or extremely lethargic, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

This article was reviewed by Dr. Stefan Petrov, a UK-trained physician (MBBS) with postgraduate certifications in ACLS and BLS. Dr. Petrov has extensive clinical experience in general medicine and emergency care, including the assessment of newborns in hospital settings. His background in medical education ensures that this information on newborn pulse oximetry is accurate, safe, and aligned with current NHS and NICOR standards.